Johansson L, Kowalski A, Mueller T C. "一种((6-Chloropyridin-3-yl)methyl)zinc pivalate (0.65 mmol/g)的合成方法" [P]. European Patent, EP 3957960 A1, 2019-08-01.
发明人沈红梅,林芳,刘建华. "Method for the Synthesis of ((6-Chloropyridin-3-yl)methyl)zinc pivalate (0.65 mmol/g)" [P]. 中国发明专利, 专利号 CN 117357136 B, 授权公告日 2025-08-14.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of ((6-Chloropyridin-3-yl)methyl)zinc pivalate (0.65 mmol/g) in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2014, 2091, 6399-6427.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of ((6-Chloropyridin-3-yl)methyl)zinc pivalate (0.65 mmol/g) as an Impurity". Anal. Chim. Acta, 2020, 824, (9), 7870-7882.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of ((6-Chloropyridin-3-yl)methyl)zinc pivalate (0.65 mmol/g) Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2018, 1983, 1196-1213.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate ((6-Chloropyridin-3-yl)methyl)zinc pivalate (0.65 mmol/g) Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2012, 1441, 937-967.